The effect of loperamide and naloxone on mouth-to-caecum transit time was evaluated by the lactulose hydrogen breath test in four men and four women. Each subject underwent tests during the administration of placebo, loperamide (12-16 mg po), naloxone (40 ,ug/kg/h by a three-hour intravenous infusion), and loperamide plus naloxone, carried out at intervals of one or two weeks. The transit time was significantly longer after loperamide, and this effect was antagonised by the concomitant administration of naloxone whereas naloxone administered alone had no effect on mean transit time. No clinically important side effects were reported.
SUMMARY
The effect of loperamide and naloxone on mouth-to-caecum transit time was evaluated by the lactulose hydrogen breath test in four men and four women. Each subject underwent tests during the administration of placebo, loperamide (12-16 mg po), naloxone (40 ,ug/kg/h by a three-hour intravenous infusion), and loperamide plus naloxone, carried out at intervals of one or two weeks. The transit time was significantly longer after loperamide, and this effect was antagonised by the concomitant administration of naloxone whereas naloxone administered alone had no effect on mean transit time. No clinically important side effects were reported.
Morphine changes the motility pattern in the gastrointestinal tract,' decreases the propulsion of its contents,2 3 reduces gastric4 and intestinal secretions5 and increases water and ions absorption.6 7 Loperamide (Lopemid Gentili, Pisa, Italy) was given as capsules of 2 mg each and naloxone hydrochloride (Narcan Crinos, Villa Guardia, Italy) was given at doses of 40 gg/kg/h. Symptoms and bowel movements during the 48 hours after the start of the test were recorded as well as the day of the menstrual cycle. The female subjects were not on oral contraceptives; four of the 16 tests on these subjects were undertaken during the luteal phase of the menstrual cycle.
Statistical analysis was performed with split-plot design (between-within subjects ANOVA) followed by Tukey's test for multiple comparisons19 and Fisher's exact test for frequency data.
Results
The orocaecal transit time in each subject according to treatments and the results of the analysis of variance are reported in the Table. The difference in transit time between sexes was not statistically significant. In men and women loperamide prolonged transit time in comparison with the other treatments (Tukey's test: p<005) while transit times during naloxone and loperamide plus naloxone administration were not statistically different from placebo or from each other. Only in subject 7, who had two to three bowel movements per week, transit time was not affected by loperamide and was reduced by naloxone.
During the 48 hours after the start of the test there was a higher frequency of subjects with no bowel movements after administration of loperamide with (five subjects) or without (six subjects) naloxone compared with placebo (two subjects) or naloxone (one subject). Borborygmi, pain and abdominal distension were present in nearly the same frequency in all treatments. Headache was more frequent in subjects treated with naloxone alone (four subjects) or with loperamide (three subjects) compared with placebo (no subjects) or loperamide (two subjects) with a statistically significant difference (p=003) between treatments A and C. Borborygmi, pain, abdominal distension and headache always disappeared within eight hours after the start of the test and were mild and easily tolerated.
Discussion
Gastrointestinal In our study the inhibition of the effect of loperamide by naloxone was obtained by administering the antagonist by the intravenous route to avoid the first passage through the liver; other authors14 reported that naloxone administered po had an effect on mouth-to-caecum transit time delayed by hydrolysed gluten, suggesting a possible purely local effect on the gut.
Lawson et al reported that the orocaecal transit time in women was significantly longer than in men.12 This result was not confirmed by our study probably because of the large inter-individual variability and the small number of subjects studied.
A possible bias which might increase the intraindividual variability of the test in women is the luteal phase of the menstrual cycle which is reported to prolong transit time. 13 We carried out four of the 16 tests in women in the luteal phase of the menstrual cycle in order to limit the time between the four tests in each subject, and the variations were not so great as to prevent obtaining a statistically significant result in the group of women.
Our results were obtained using the lactulose hydrogen breath test, a simple and well tolerated investigation technique: the side effects reported were mild, quickly self-limiting and easily tolerated by the volunteers.
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